Gene · 1585
Papers3,065
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
41 to 60 of 3,065
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Safety and Efficacy of Lorundrostat in Uncontrolled Hypertension: A Systematic Review and Meta-analysis. | J Cardiovasc Pharmacol | 2026 | 42407042 | PubTator, text mining | PubMed |
| Genetics of hypertension in populations affected by the Aral Sea ecological crisis: A case-control study. | PLoS One | 2026 | 42406770 | PubTator, text mining | PubMed |
| Efficacy and safety of baxdrostat in the management of uncontrolled hypertension: a systematic review and meta-analysis. | Am J Hypertens | 2026 | 42405524 | PubTator, text mining | PubMed |
| Evidence for de novo synthesis of corticosteroids in the human ovary. | Hum Reprod | 2026 | 42402373 | PubTator, text mining | PubMed |
| A CYP11B2 variant (rs7831617) is associated with lower blood pressure and a reduced risk of incident hypertension. | Sci Rep | 2026 | 42399349 | PubTator, text mining | PubMed |
| New Drugs on the Horizon for Hypertension. | Adv Kidney Dis Health | 2026 | 42397328 | PubTator, text mining | PubMed |
| Comparison of the Efficacy of Different Treatment Regimens for Resistant Hypertension: A Systematic Review and Network Meta-Analysis. | J Evid Based Med | 2026 | 42396775 | PubTator, text mining | PubMed |
| Baxdrostat (Baxfendy) - an aldosterone synthase inhibitor for hypertension. | Med Lett Drugs Ther | 2026 | 42348770 | PubTator, text mining | PubMed |
| Efficacy and Safety of Baxdrostat for Hypertension: A Systematic Review and Meta-Analysis of Three Phase 2/3 Randomized Controlled Trials. | Clin Cardiol | 2026 | 42334050 | PubTator, text mining | PubMed |
| Baxdrostat versus osilodrostat: steroid biosynthesis in human adrenocortical cells. | Endocr Connect | 2026 | 42307048 | PubTator, text mining | PubMed |
| Post-Hoc Analysis on the Effects of Vicadrostat/Empagliflozin by CKD Severity/Hypertension Status. | Kidney Int Rep | 2026 | 42292647 | PubTator, text mining | PubMed |
| CXCR4 reduces aldosterone synthesis via regulating CYP11B2 expression. | Genes Dis | 2026 | 42290661 | PubTator, text mining | PubMed |
| Combined Aldosterone Synthase and SGLT2 Inhibition: A Recipe for Success in CKD with Uncontrolled Blood Pressure? | Curr Hypertens Rep | 2026 | 42283874 | PubTator, text mining | PubMed |
| Aldosterone, not only an adrenal mineralocorticoid: An updated review of its functions, mechanisms, biosynthesis, hormone system and regulation in multiple organs and tissues. | J Physiol Pharmacol | 2026 | 42272278 | PubTator, text mining | PubMed |
| A modifiable driver of dementia: cognitive impairment in primary aldosteronism. | Hypertens Res | 2026 | 42270765 | PubTator, text mining | PubMed |
| Safety and efficacy of lorundrostat, an aldosterone synthase inhibitor, in patients with uncontrolled hypertension: A systematic review and meta-analysis. | Medicine (Baltimore) | 2026 | 42260805 | PubTator, text mining | PubMed |
| The Expression of Placental 17β-Hydroxysteroid Dehydrogenase Genes Is Associated with the Elevation of Active Androgens and Estrogens in Pregnant Women, but Does Not Affect 11-Oxygenated C19 Steroids. | Int J Mol Sci | 2026 | 42196271 | PubTator, text mining | PubMed |
| Aldosterone synthase inhibitors for the treatment of cardiovascular disease. | Nat Rev Endocrinol | 2026 | 42174224 | PubTator, text mining | PubMed |
| An unexpected finding of apparent bilateral aldosterone suppression after superselective adrenal venous sampling: a case report. | Blood Press | 2026 | 42165404 | PubTator, text mining | PubMed |
| Aldosterone synthase inhibitors: a new option for antihypertensive, cardio-renal protection. | Hypertens Res | 2026 | 42162198 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1585/papers?page=3